Please login to the form below

alpharadin

This page shows the latest alpharadin news and features for those working in and with pharma, biotech and healthcare.

FDA clears Bayer/ Algeta's prostate cancer radiotherapy

Analysts have predicted that Xofigo (formerly known as Alpharadin) could achieve sales of $650m within three years of launch and more than $1bn a year at its peak if follow-up

Latest news

Bayer pins hopes on five potential blockbusters

Bayer pins hopes on five potential blockbusters. Riociguat, alpharadin, Stivarga, Eylea, and Xarelto expected to reach sales of 5.5bn by 2015. ... The German company's expectations are high for it yet to be approved riociguat and alpharadin (radium-223
FDA fast-tracks Bayer's prostate cancer radiotherapy

FDA fast-tracks Bayer's prostate cancer radiotherapy. Priority review for radium-223 dichloride, formerly called Alpharadin. ... The FDA granted priority review status to radium-223 dichloride - formerly called Alpharadin - for the treatment of
New hope for castration-resistant prostate cancer

Another bone-targeting agent in phase III trials of use in patients with CRPC and bone metastases is radium-223 chloride (Alpharadin; Algeta, Bayer Healthcare), a first-in-class, highly targeted
Developing drugs to conquer cancer

Bayer HealthCare discussed phase III results concerning regorafenib in gastrointestinal stromal tumour (GIST) and in colorectal cancer, as well as the final overall survival analysis of radium-223 (Alpharadin) data in
Bayer raises 2012 forecasts on increasing revenues

Bayer has previously highlighted four potential blockbusters in its late-stage pipeline, including Xarelto, Eylea (aflibercept) for wet age-related macular degeneration (AMD) and two cancer drugs, namely alpharadin for bone

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest appointments

Bayer’s former oncology head Robert Rosen joins AP Pharma

Rosen also led premarket activities for Stivarga (regorafenib) in its indications for gastrointestinal stromal tumours and colon cancer, as well as for alpharadin in prostate cancer.
Former Bayer oncology head Robert Rosen joins AP Pharma's board

He was also involved in pre-market activities for regorafenib in the treatment of patients with gastrointestinal stromal tumours and colon cancer, as well as alpharadin for prostate cancer.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Project Manager - Medical Writing: Great salary and bebefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Business Unit Head, Medical Communications, London: Excellent package

Editorial Director – Medical Education (MedComms): Neg

Account Manager: £40, 000 - £45, 000 benefits

Home based, Editorial Team Leader, Medical Communications: Excellent package

Home based, Principal Medical Writer, Medical Communications: Excellent package

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Home based, Chief Medical Writer, Medical Communications: Excellent package

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Senior Account Manager: Competitive salary commensurate with experience

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Home based, Senior Medical Writer, Medical Communications: Excellent package

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Multi-Channel Account Managers - Road / Homebased – Full or Part...: Competitive salary

Client Services Director – Healthcare Advertising - London: Neg

Delivery Manager/ Head of Delivery – Executive Search: Neg

Client Services Director - Med Comms: Great salary and bebefits

Subscribe to our email news alerts

PMHub

Add my company

Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...